期刊文献+

第一批赖氨酸升压素国家标准品的制备 被引量:10

Preparation of the first batch of national standard for lysine vasopressin
原文传递
导出
摘要 目的制备第一批赖氨酸升压素国家标准品。方法以英国国家生物制品检定所(National Institute for Biological Standards and Control,NIBSC)提供的WHO第一批赖氨酸升压素国际标准品作为标准,选择4个实验室,采用《中国药典》二部(2010版)附录ⅫA升压素生物测定法对第一批赖氨酸升压素国家标准品待标品的生物效价进行协作标定,并比较二者的高效液相色谱(HPLC)主峰保留时间;按照《中国药典》二部(2010版)附录ⅧM水分测定法,第一法(费休氏法)B.库仑滴定法测定第一批赖氨酸升压素国家标准品待标品的水分含量。结果第一批赖氨酸升压素国家标准品待标品经协作标定,确定其生物效价为4.0 IU/支;其HPLC主峰保留时间与第一批赖氨酸升压素国际标准品一致;其水分含量为2.9%。结论本批待标品可作为第一批赖氨酸升压素国家标准品,以供赖氨酸升压素效价测定、鉴别及升压物质检查使用。 Objective To prepare the first batch of national standard for lysine vasopressin. Methods The biological potency of the first batch of candidate national standard for lysine vasopressin was collaboratively calibrated by four laboratories by the method in Appendix Ⅻ A in Chinese Pharmacopoeia(Volume Ⅱ,2010 edition)using the first batch of WHO international standard provided by National Institute for Biological Standards and Control(NIBSC)as standard.The retention times of main peaks of the two standards on HPLC profile were compared. The moisture content in national standard to be calibrated was determined by coulometric titration in Appendix Ⅷ M in Chinese Pharmacopoeia(VolumeⅡ,2010 edition). Results The biological potency of the candidate national standard was defined as 4. 0 IU per container by collaborative calibration,while the retention time of main peak on HPLC profile was consistent with that of international standard,and the moisture content was 2. 9%. Conclusion The candidate may be used as the first batch of national standard for lysine vasopressin for determination of potency,identification and test for vasopressor substance.
出处 《中国生物制品学杂志》 CAS CSCD 2014年第7期923-926,共4页 Chinese Journal of Biologicals
关键词 赖氨酸升压素 标准品 生物效价 高效液相色谱 Lysine vasopressin Standard Biological potency High performance liquid chromatography
  • 相关文献

同被引文献57

  • 1刘绍基,陈卫民,何家乐.血管加压素的研究进展[J].小儿急救医学,2005,12(3):226-227. 被引量:6
  • 2钱德明,刘群丽,张媛,汪佩华.尿促性素第三批国家标准品的标定[J].中国药品标准,2007,8(4):50-52. 被引量:2
  • 3钱德明,刘群丽,张媛,邵燕,杨赟昀,孙圆媛,华晓东,张月玲,芮菁,朱社敏,匡荣.第九批绒促性素国家标准品的建立[J].中国药事,2007,21(10):816-818. 被引量:2
  • 4ChP 2010.Vol Ⅱ(中国药典2010年版.二部)[S].2010:976.
  • 5PAULINE C, ALLAN EH. Optogenetic activation of GnRH neurons reveals minimal requirements for pulsatile luteinizing hormone secretion[J]. Proc Natl Acad Sci USA, 2014, 111(51):18387.
  • 6ZHOU HJ(周海钧). The Drug Bioassay(药品生物检定)[M]. Beijing(北京):People's Medical Publishing House(人民卫生出版社), 2005:223.
  • 7LENG W(冷炜). Bioassay of the Drug(药品的生物检定)[M]. Beijing(北京):Meteorological Press(气象出版社), 1995:114.
  • 8QIAN DM(钱德明), LIU QL(刘群丽), ZHANG Y(张媛). Collaboration of the third national standard reference potency for human menopausal gonadotropin(尿促性素第三批国家标准品的标定)[J]. Drug Stand China(中国药品标准), 2007, 8(5):49.
  • 9National Institute for the Control of Pharmaceutical and Biological Products(中国药品生物制品检定所). Standard Operating Procedure for Chinese Drug Test(中国药品检验标准操作规范)[M]. Beijing(北京):China Medical Science Press (中国医药科技出版社), 2010:489.
  • 10ROSE MP, GAINES DAS RE, BALEN AH. Definition and measurement of follicle stimulating hormone[J]. Endocr Rev, 2000, 21(1): 5.

引证文献10

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部